PFRandy is a very professional and responsible individual who is able to handle large and complex tasks as well as small ones meeting or exceeding customer expectations. In addition Randy is a great individual and excellent at motivating people. I highly recommend Randy and the work he does.
PPRandy is a top tier manager with the ability to recognize talent. He provides growth opportunities for his employees and makes every effort to help them advance their careers. Randy easily navigates the multi-functional environment of product development.
CEO & President
Acutus Medical | January 2011 - Current
Acutus Medical is venture capital (VC) funded company developing a portfolio of products to become the only single-solution provider in a market with a substantial unmet clinical need. Electrophysiology is a high growth market with a clear need for a leap-frog technology to address the unmet need for a scientific, medical evidence-based approach to treating Atrial Fibrillation, Ventricular Tachycardia and the other complex arrhythmia's.
Healthfundr | October 2013 - Current
Healthfundr makes it possible for startups to raise early stage (seed) capital through Medtech Crowd Funding.
Aperiam Medical | April 2014 - Current
New technology for the treatment of AF
Vice President of Research & Development
Medtronic - AF Solutions | January 2009 - December 2010
Transferred to Medtronic post acquisition of Ablation Frontiers. Moved into the VP of R&D for AF Solutions to Research & Development technology for the treatment of Atrial Fibrillation
Co-founder & VP
Ablation Frontiers, Inc. | May 2004 - January 2009
Ablation Frontiers was a team of dedicated medical scientists, biomedical engineers, and other professionals focused on the development of a novel RF technology and multiple catheters to restore normal heart function to individuals afflicted with cardiac arrhythmia's.
Carmeron Health | December 2002 - Current 2002
Director of R&D
Edwards Lifesciences | December 2002 - Current 2004
Managed a group of engineers at an off-site facility developing products for the treatment of Peripheral vascular disease using self-expanding stent technology and PTFE combinations. Later sold to Bard
CTO and Co-founder
Cardiostream | January 2000 - Current 2002
First technology patented for the detection and treatment of vulnerable plaque. Company now located in Europe and progressing through clinical development: http://www.cryotherapeutics.com/
Micro Therapeutics | August 1997 - August 1999
Managed the early stage development of products related to the treatment of neuro AVM & aneurysms.
Medtronic, Inc. | December 1990 - August 1997
Started as a MFG Engineering for the 14K line and left managing the R&D group for Medtronic first ever stent program (Wiktor stent)
Arizona State University
Pursuing a degree in Finance | 2012 - 2014
University of California, Los Angeles
Master of Science (MSc) | Pre-Clinical Research | 1996 - 1998
Arizona State University
MS | Engineering | 1981 - 1986